Travere Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results
Travere Therapeutics (NASDAQ: TVTX) has announced it will release its fourth quarter and full year 2024 financial results on Thursday, February 20, 2025, after U.S. financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide a business update. Investors can access the webcast through Travere's investor relations website, and a replay will be available for 30 days following the live presentation.
Travere Therapeutics (NASDAQ: TVTX) ha annunciato che pubblicherà i suoi risultati finanziari del quarto trimestre e dell'intero anno 2024 giovedì 20 febbraio 2025, dopo la chiusura dei mercati finanziari statunitensi. L'azienda ospiterà una conferenza telefonica e un webcast alle 16:30 ET per discutere i risultati e fornire un aggiornamento aziendale. Gli investitori possono accedere al webcast attraverso il sito web delle relazioni con gli investitori di Travere, e una registrazione sarà disponibile per 30 giorni dopo la presentazione dal vivo.
Travere Therapeutics (NASDAQ: TVTX) ha anunciado que publicará sus resultados financieros del cuarto trimestre y del año completo 2024 el jueves 20 de febrero de 2025, después del cierre de los mercados financieros de EE. UU. La compañía llevará a cabo una llamada de conferencia y un webcast a las 4:30 p.m. ET para discutir los resultados y proporcionar una actualización comercial. Los inversores pueden acceder al webcast a través del sitio web de relaciones con inversores de Travere, y una grabación estará disponible durante 30 días después de la presentación en vivo.
Travere Therapeutics (NASDAQ: TVTX)는 2024년 4분기 및 연간 재무 결과를 2025년 2월 20일 목요일, 미국 금융 시장이 마감된 후 발표할 것이라고 발표했습니다. 회사는 오후 4시 30분 ET에 결과를 논의하고 비즈니스 업데이트를 제공하기 위해 전화 회의 및 웹캐스트를 개최합니다. 투자자는 Travere의 투자자 관계 웹사이트를 통해 웹캐스트에 접근할 수 있으며, 라이브 발표 후 30일 동안 다시 볼 수 있습니다.
Travere Therapeutics (NASDAQ: TVTX) a annoncé qu'elle publiera ses résultats financiers du quatrième trimestre et de l'année 2024 le jeudi 20 février 2025, après la fermeture des marchés financiers américains. La société organisera un appel conférence et un webcast à 16h30 ET pour discuter des résultats et fournir une mise à jour sur l'entreprise. Les investisseurs peuvent accéder au webcast via le site web des relations investisseurs de Travere, et un enregistrement sera disponible pendant 30 jours après la présentation en direct.
Travere Therapeutics (NASDAQ: TVTX) hat bekannt gegeben, dass die Finanzergebnisse des vierten Quartals und des gesamten Jahres 2024 am Donnerstag, den 20. Februar 2025, nach Schließung der US-Finanzmärkte veröffentlicht werden. Das Unternehmen wird um 16:30 Uhr ET eine Telefonkonferenz und einen Webcast abhalten, um die Ergebnisse zu besprechen und ein Unternehmensupdate bereitzustellen. Investoren können über die Investor-Relations-Website von Travere auf den Webcast zugreifen, und eine Aufzeichnung wird 30 Tage nach der Live-Präsentation verfügbar sein.
- None.
- None.
SAN DIEGO, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report fourth quarter and full year 2024 financial results on Thursday, February 20, 2025, after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET.
The webcast and dial-in information can be accessed on the Investor page of Travere’s website at ir.travere.com/events-presentations. Following the live webcast, an archived version of the call will be available for 30 days on the Company’s website.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.
Contact Info
| Media: 888-969-7879 mediarelations@travere.com | Investors: 888-969-7879 IR@travere.com |
FAQ
When will Travere Therapeutics (TVTX) report Q4 and full year 2024 earnings?
What time is TVTX's Q4 2024 earnings call?
How can I access TVTX's Q4 2024 earnings webcast?
How long will TVTX's Q4 2024 earnings call replay be available?
